Clinical Aspects of Detection and Imaging of Differentiated Thyroid Tumors

  • J. Frühling
Conference paper


Thyroid cancer, especially the differentiated kind, is one of the most popular subjects in the oncological literature. Moreover, this disease is one of the “favorite children” of nuclear medicine for evident historical reasons: the administration of 131-I for diagnostic and therapeutic reasons has for more than 40 years been strongly involved in the management of thyroid cancer, which therefore is among the first diseases where nuclear medicine has assumed a decisive role as a distinct speciality.


Thyroid Cancer Thyroid Carcinoma Thyroid Nodule Prognostic Index Differentiate Thyroid Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Altenbrunn H-J (1984) Die nuklearmedizinische Diagnostik der Schilddrüsenmalignome einschließlich der Metastasendiagnostik. In: Altenbrunn H-J (ed) Fortschritte der Onkologie. 12. Nuklearmedizinische Diagnostik maligner Tumoren. Akademie Verlag, Berlin, pp 33–58Google Scholar
  2. 2.
    Beierwaltes WH (1978) The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med VIII:79–94CrossRefGoogle Scholar
  3. 3.
    Biersack HJ et al. (1981) Zur Behandlung des Schilddrusenkarzinoms. Dtsch Med Wochenschr 106:350–395CrossRefGoogle Scholar
  4. 4.
    Blahd, WH (1979) Treatment of malignant thyroid disease. Semin Nucl Med EX:95–99CrossRefGoogle Scholar
  5. 5.
    Byar DP et al. (1979) A prognostic index for thyroid carcinoma. A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033–1041PubMedCrossRefGoogle Scholar
  6. 6.
    Gemsenjäger E et al. (1985) Therapie des differenzierten Schilddrüsenkarzinoms. Schweiz Med Wochenschr 115:153–159PubMedGoogle Scholar
  7. 7.
    Hoefnagel CA et al. (1983) Usefulness of thallium-201 total body scintigraphy in postoperative thyroid carcinoma. In: Carpi A (ed) Clinical and pathological advances in thyroid tumors. ETS, Pisa (in press)Google Scholar
  8. 8.
    Ladurner D, Seeber G (1984) Das follikuläre Schilddrüsenkarzinom. (Eine multivariate Analyse). Schweiz Med Wochenschr 114:1087–1092PubMedGoogle Scholar
  9. 9.
    Mazzaferri EL (1981) Papillary and follicular thyroid cancer. Ann Rev Med 32:73–91PubMedCrossRefGoogle Scholar
  10. 10.
    Molitch ME et al. (1984) The cold thyroid nodule: an analysis of diagnostic and therapeutic options. Endocr Rev 9:185–199CrossRefGoogle Scholar
  11. 11.
    Rösler H, Walther E (1984) Die Strahlentherapie der Struma maligna. In: Heilmann H-P (ed) Radiation therapy of malignant tumors. Springer, Berlin Heidelberg New York Tokyo, Handbuch der medizinischen Radiologie vol 19, part 5, pp 1–87Google Scholar
  12. 12.
    Tubiana M et al. (1985) Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794–804PubMedCrossRefGoogle Scholar
  13. 13.
    Ramacciotti CE et al. (1984) Diagnostic accuracy and use of aspiration biopsy in the management of thyroid nodules. Arch Intern Med 144:1169–1174PubMedCrossRefGoogle Scholar
  14. 14.
    Werk EE et al. (1984) Cancer in thyroid nodules. A community hospital survey. Arch Intern Med 144:474–476PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • J. Frühling
    • 1
  1. 1.Institut Jules BordetCentre des Tumeurs de l’ Université Libre de BruxellesBrusselsBelgium

Personalised recommendations